Investigation of Omega-3 Polyunsaturated Fatty Acid Biological Activity in a Tissue-Engineered Skin Model Involving Psoriatic Cells.
12-Hydroxy-5,8,10,14-eicosatetraenoic Acid
/ analysis
Cell Differentiation
/ drug effects
Cell Proliferation
/ drug effects
Dietary Supplements
Extracellular Signal-Regulated MAP Kinases
/ physiology
Humans
Keratinocytes
/ drug effects
Leukotriene B4
/ analysis
Psoriasis
/ drug therapy
Tissue Engineering
alpha-Linolenic Acid
/ administration & dosage
Journal
The Journal of investigative dermatology
ISSN: 1523-1747
Titre abrégé: J Invest Dermatol
Pays: United States
ID NLM: 0426720
Informations de publication
Date de publication:
10 2021
10 2021
Historique:
received:
15
05
2020
revised:
25
02
2021
accepted:
26
02
2021
pubmed:
16
4
2021
medline:
15
12
2021
entrez:
15
4
2021
Statut:
ppublish
Résumé
Clinical studies have shown that diets enriched with omega-3 (also know as n-3) polyunsaturated fatty acids could relieve the symptoms of patients with psoriasis. However, the mechanisms involved remain poorly understood. The aim of this study was to investigate the effects of α-linolenic acid (ALA) on the proliferation and differentiation of psoriatic keratinocytes in a three-dimensional skin model. Skin models featuring healthy (healthy substitute) or psoriatic (psoriatic substitute) cells were engineered by the self-assembly method of tissue engineering using a culture medium supplemented with 10 μM ALA in comparison with the regular unsupplemented medium. ALA decreased keratinocyte proliferation and improved psoriatic substitute epidermal differentiation, as measured by decreased Ki67 staining and increased protein expression of FLG and loricrin. The added ALA was notably incorporated into the epidermal phospholipids and metabolized into long-chain n-3 polyunsaturated fatty acids, mainly eicosapentaenoic acid and n-3 docosapentaenoic acid. ALA supplementation led to increased levels of eicosapentaenoic acid derivatives (15-hydroxyeicosapentaenoic acid and 18-hydroxyeicosapentaenoic acid) as well as a decrease in levels of omega-6 (also know as n-6) polyunsaturated fatty acid lipid mediators (9-hydroxyoctadecadienoic acid, 12-hydroxyeicosatetraenoic acid, and leukotriene B
Identifiants
pubmed: 33857488
pii: S0022-202X(21)01126-X
doi: 10.1016/j.jid.2021.02.755
pii:
doi:
Substances chimiques
alpha-Linolenic Acid
0RBV727H71
Leukotriene B4
1HGW4DR56D
12-Hydroxy-5,8,10,14-eicosatetraenoic Acid
59985-28-3
Extracellular Signal-Regulated MAP Kinases
EC 2.7.11.24
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
2391-2401.e13Subventions
Organisme : CIHR
ID : MOP-311262
Pays : Canada
Informations de copyright
Copyright © 2021 The Authors. Published by Elsevier Inc. All rights reserved.